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Periodic fever syndromes (PFSs) comprise a subset
of the hereditary autoinflammatory disorders that
are defined by recurrent self-resolving attacks of
systemic inflammatory reactions in the absence of
infection or autoimmunity. Recent advances have
led to the discovery that members of a new family
of genes, the PYRIN family, account for several he-
reditary PFSs. Here we discuss new insights into the
function of PYRIN proteins and the molecular basis
of PFSs.
 
Periodic Fever Syndromes.
 
The genetic cause of six hered-
itary PFSs has been identified: Familial Mediterranean
Fever (FMF), TNF receptor–associated periodic syndrome
(TRAPS), hyperimmunoglobulinemia D and PFS (HIDS),
familial cold autoinflammatory syndrome (FCAS)/familial
cold urticaria (FCU), Muckle-Wells syndrome (MWS), and
neonatal-onset multisystem inflammatory disease (NOMID)/
chronic infantile neurologic cutaneous and articular syndrome
(CINCA). More than 70 yr ago, the first autosomal recessive
hereditary PFS, now known FMF, was defined. FMF is
characterized by episodic fever spikes lasting for days, fol-
lowed by attack-free periods as long as several years. The
gene responsible for FMF was reported in 1997 and denoted
 
MEFV
 
, and the protein was named Pyrin (Marenostrin) (1,
2). The Pyrin protein consists of a conserved NH
 
2
 
-terminal
PYRIN domain, followed by a COOH-terminal B-box
zinc finger, a PRY/SPRY domain, and two overlapping
nuclear localization signals (Fig. 1). Mutations in the gene
encoding proline serine threonine phosphatase–interacting
protein (PSTPIP1), a Pyrin-interacting protein, are associated
with the dominantly inherited autoinflammatory syndrome
of pyogenic arthritis, pyodermagangrenosum, and acne
(PAPA). These mutations accentuate the interaction between
Pyrin and PSTP1 (3). Pyrin and PSTPIP1 proteins associate
with the cytoskeleton (4), but the significance of this obser-
vation is unclear.
HIDS or Dutch-type periodic fever is another autosomal
recessive PFS characterized by fever attacks of up to a
week, accompanied by constitutively elevated levels of serum
IgD. In 1999, a candidate gene for HIDS was identified,
 
MVK
 
, encoding mevalonate kinase (5, 6). Indeed, patients
with HIDS show increased concentrations of mevalonic
acid during fever episodes, correlating with reduced meval-
onate kinase activity, suggesting that HIDS represents a
metabolic defect in the isoprenoid biosynthesis, presumably
resulting not only in periodic production of abnormal levels of
pyrogenic isoprenoids but also in increased IL-1
 
 
 
 secretion.
The first defined PFS with an autosomal dominant mode
of inheritance was TRAPS, initially referred to as Familial
Hibernian Fever, which is caused by mutations in the gene
encoding TNFR1 (7). Given the prominent role of TNF
receptors in inflammatory responses, it is not surprising that
polymorphisms in this gene are linked to a PFS.
In 1999, two PFSs, namely FCAS (or FCU) and MWS,
were linked to the gene 
 
CIAS1
 
 (8, 9). The encoded pro-
tein, Cryopyrin, is a member of the PYRIN and NACHT
domain–containing (PAN) family of proteins, which has at
least 15 human members (Table I). These proteins contain a
characteristic combination of three domains, including a
PYRIN domain, a specific nucleotide-binding fold (NACHT
domain), and several tandem copies of leucine-rich repeats
(LRRs) similar to the extracellular domain of Toll-like
receptors (TLRs) (Fig. 1). Mutations in 
 
CIAS1
 
 are found
mainly within or in the vicinity of the NACHT domain,
which is thought to mediate oligomerization of this protein.
Mutations in 
 
CIAS1
 
 are also associated with another autoin-
flammatory disorder, CINCA (NOMID), a disorder where
short recurrent fever episodes are common, though severe
arthropathic, neurologic, and dermatologic symptoms pre-
dominate (10, 11). Among the 20 human genes that encode
a NACHT domain, hereditary mutations associated with in-
flammatory diseases have also been identified in 
 
NOD2
 
,
which encodes a protein with a similar architecture to Cryo-
pyrin except that it contains a pair of caspase recruitment
domains (CARDs) instead of the PYRIN domain. Mutations
in 
 
NOD2
 
 have been linked to kinships with familial Crohn’s
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disease, a form of inflammatory bowel disease, and Blau syn-
drome, which causes granulomatous arthritis, uveitis, and
skin rash (12), with mutations tending to reside in either the
LRR or NACHT domain, respectively, resulting putatively
in either loss of function (familial Crohn’s disease) or gain of
function (Blau syndrome).
 
The PYRIN Domain: A Link To Inflammatory Pathways.
 
With the exception of HIDS, all characterized PFS involve
proteins containing the death domain fold (DDF), consist-
ing of a characteristic bundle of five to six 
 
 
 
-helices. Four
subfamilies have been identified, including the death do-
main, death effector domain, CARD, and PYRIN do-
main, which mediate homotypic protein–protein interac-
tions. To date, identified downstream effectors of DDFs
include caspases, a family of cysteine proteases, and proteins
linked to activation of Jun NH
 
2
 
-terminal kinase and kinases
that activate NF-
 
 
 
B family members.
The PYRIN domain is the most recently recognized
DDF and also the most recently evolved and found only
among vertebrates. The three-dimensional structure of
PYRIN domains from apoptosis-associated speck-like
protein containing a CARD (ASC), a small adaptor protein
that contains both a PYRIN and a CARD domain, and
NALP1 have been solved recently by NMR, revealing the
characteristic DDF fold. The role (if any) of post-transla-
tional modifications in regulating PYRIN–PYRIN interac-
tions is unclear, though TNF stimulation can induce phos-
phorylation of at least two PYRIN family proteins (13).
The PYRIN domain can be found in association with
numerous other types of domains (Fig. 1) that may either
serve as sensors of changes in cellular environment or effec-
tors that trigger responses. PYRIN domains can bind indi-
rectly to at least two proteins important in inflammation:
pro–caspase-1 and the I
 
 
 
B kinase (IKK) complex, resulting
in either activation or inhibition of these enzymes.
Caspase-1 is primarily involved in proteolytic processing
and activation of proinflammatory cytokines, pro-1
 
 
 
 and
pro–IL-18, though also capable of participating in apoptosis
in certain pathological contexts. Some PYRIN proteins
connect to pro–caspase-1 via ASC (Fig. 1) (14). The
CARD of ASC can bind pro–caspase-1, thus acting as a
molecular bridge to other PYRIN proteins mediated via
their PYRIN domains (15). ASC represents only one of
two genes in the human genome combining CARD and
PYRIN domains, the other being NALP1 (Fig. 1). NALP1
uses its CARD to bind pro–caspase-5 and the PYRIN do-
main to link via ASC to pro–caspase-1, resulting in a pro-
tein complex that controls activation of caspases-1 and -5,
and which has been dubbed the “inflammasome” (16). Cryo-
pyrin and NALP2 also form inflammasomes, but distinct
from NALP1 (17), these PANs associate with ASC, cardi-
nal, and pro–caspase-1 but not pro–caspase-5. The central
role of ASC in host defense responses linked to caspase-1
activation was revealed recently by gene ablation studies in
mice, showing a severe defect in caspase-1 activation in
macrophages from 
 
Asc
 
 
 
/
 
 
 
 mice in response to TLR activa-
tion and infection with intracellular pathogens and increased
resistance to endotoxic shock of these mice (18). In contrast
to wild-type Cryopyrin, hereditary mutants spontaneously
associate with ASC and trigger caspase-dependent process-
ing of pro–IL-1
 
 
 
 (19). Macrophages from MWS patients
display spontaneous activation of caspase-1 and secretion of
active IL-1
 
 
 
. Similarly, patients suffering from NOMID
have elevated serum cytokines (17). Peripheral blood lym-
phocytes isolated from PAPA patients, which produce mu-
tant forms of the Pyrin-interacting protein PSTPIP1, also
secrete elevated levels of IL-1
 
 
 
, correlating with increased
PSTPIP1-Pyrin association in these cells (3). Also FMF-
associated Pyrin mutations induce an increase in bioactive
IL-1
 
 
 
 when transfected into monocytes (20). Together, these
results suggest that hereditary alterations in these PYRIN
family proteins or their interacting partners represent gain of
function mutations, where the proteins constitutively signal.
However, macrophages from 
 
Pyrin
 
 
 
/
 
 
 
 mice exhibit height-
ened sensitivity to LPS and produce more (not less) active
caspase-1 and IL-1
 
 
 
 (20). Thus, one cannot eliminate the
Figure 1. PYRIN domain and related proteins. PYRIN domain and some related proteins are presented. Domains shown include: CARD; hemato-
poietic interferon-inducible nuclear proteins with a 200-amino-acid repeat (HIN200/IFI20); NAIP, CIITA, HET-E, and TP1 (NACHT); LRR; bacu-
lovirus inhibitor of apoptosis repeat (BIR); Trp-Asp 40 (WD40); activation domain (AD); NACHT-associated domain (NAD), TIR; coiled-coil (CC);
cysteine-rich domain (CYS); transmembrane domain (TM); zinc finger B-box (zf-B-box); Dictyostelium discoideum dual specificity kinase SplA and ryano-
dyne receptor (SPRY); SPRY associated (PRY); domain with function to find (FIIND). 
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possibility that wild-type versions of some of these proteins
normally suppress IL-1
 
 
 
 production, with the hereditary
mutations representing loss of function mutations.
Some PYRIN proteins have been shown to associate
with the IKK complex, affecting activation of NF-
 
 
 
B (13,
21, 22), a family of transcription factors that directly con-
trols expression of a variety of genes involved in inflamma-
tion and host defense. How PYRIN domains bind IKK
complex proteins is unclear, though one route may again
involve ASC. The CARD of ASC can bind Cardiak (Rick,
Rip2), which in turn binds IKK
 
 
 
 (15). Alternatively, ASC
conceivably could connect to IKK
 
 
 
 via Cardinal, which
contains a CARD that can bind ASC (unpublished data)
and also reportedly directly binds IKK
 
 
 
 (23). However,
other routes to IKK complex proteins probably also exist,
as suggested for the PAN2 protein (22). Both Cryopyrin
 
Table I.
 
PAN Family Proteins
 
PAN
Alternative
name Chromosome Expression
 
a
 
Inducer Domains
 
b
 
LRRs
Length 
(aa)/kD
Cryopyrin PYPAF1
NALP3
1q44 C, G, T, M TNF
 
↑
 
, 
PAMPs
 
↑
 
P-N-A-L 9 1,034/118
PAN1 PYPAF2
NALP2 
NBS1
19q13.4 Ubiquitous expressed;
high in tumors
Cell cycle 
regulated
P-N-A-L 8 1,062/121
PAN2 PYPAF4
NALP4
19q13.42 B, M, F, pl, lg,
li, ki, pa, sp, th
P-N-A-L 8 994/113
PAN3 PYPAF5
NALP6
11p15 T, E, G P-N-A-L 5 892/99
PAN4 NALP8 19q13.4 P-N-A-L 7 1,029/117
PAN5 NALP10
Pynod
11p15 P-N-A-L 0 655/75
PAN6 PYPAF7
NALP12
Monarch-1
19q13.4 L, DC, M, E, G NO
 
↑
 
TNF
 
↓
 
,
IFN
 
 
 
↓
 
P-N-A-L 11 1,061/120
PAN7 PYPAF3
NALP7
NOD12
11q13.42 P-N-A-L 9 980/112
PAN8 NALP14 11p15.4 P-N-A-L 12 1,093/125
PAN9 19q13.4 P-N-A-L 9 1,014/115
PAN10 PYPAF6
NALP11
NOD17
19q13.42 B P-N-A-L 9 1,033/118
PAN11 PYPAF8
NALP5
mater
11q13.42 Oocyte specific P-N-A-L 13 1,200/134
PAN12 NALP9 19q13.4 P-N-A-L 10 986/113
PAN13 NALP13 19q13.4 P-N-A-L 9 1,043/119
PAN14 NOD27 16q13 M, breast cancer
 
↑
 
,
leukemia
 
↓
 
,
renal tumors
 
↓
 
LPS
 
↓
 
P-N-A-L 20 1,866/205
NAC DEFCAP
CARD7
NALP1
17p12.13 M, B LPS
 
↓
 
, 
Ionomycin
 
↓
 
PMA
 
↓
 
P-N-L-A-F-C 5 1,429/161
 
a
 
B, B cells; C, chondrocytes; E, eosinophils; G, granulocytes; M, monocytes; T, T cells; ki, kidney; li, liver; lg, lung; pa, pancreas; pl, placenta; sp,
spleen; th, thymus; 
 
↑
 
, induction;
 
 ↓
 
, inhibition.
 
b
 
P, PYRIN domain; N, NACHT; A, angiotensin receptor–related (or NAD); L, LRR; C, CARD; F, FIIND; 
 
↑
 
, induction;
 
 ↓
 
, inhibition. 
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and Pyrin utilize ASC to link to NF-
 
 
 
B activation path-
ways. However, at least in overexpression situations, Pyrin
has also been reported to interfere with the interaction of
ASC and Cryopyrin (13, 21, 24). Moreover, hereditary
mutations found in Cryopyrin also show enhanced NF-
 
 
 
B
activation in collaboration with ASC compared with wild-
type Cryopyrin, whereas Cryopyrin expressed in the ab-
sence of ASC blocks activation of NF-
 
 
 
B (19, 25). Thus,
complex networks of interactions among PYRIN domain–
containing proteins may set thresholds for NF-
 
 
 
B induc-
tion, assuring that inflammation is induced only if the
proper stoichiometry ratios of components are present in
protein complexes containing PYRIN family proteins.
Although PAN family proteins are capable of regulating
NF-
 
 
 
B activity, the physiological importance of this func-
tion of PYRIN domain–containing proteins is unknown. In
this regard, recent clinical experience with use of recombi-
nant IL-1 receptor antagonists has demonstrated marked
benefits in patients harboring Cryopyrin mutations (26), at-
testing to the importance of excessive IL-1 production in
this PAN family protein disease. It would be interesting to
compare this result with drugs such as IKK inhibitors or
proteasome inhibitors that suppress NF-
 
 
 
B induction.
 
A Network of PYRIN Domain Interactions.
 
Another im-
portant goal of future research is to delineate which of the
 
 
 
21 PYRIN domain–containing proteins encoded in the
human genome interact with each other and what the func-
tional consequences of those interactions are. One insightful
example of regulatory interactions among PYRIN domain–
containing proteins is found in POP1, a recently identified
small protein that consists only of a PYRIN domain (Fig.
1). POP1 binds ASC and interferes with its ability to collab-
orate with Pyrin or Cryopyrin in NF-
 
 
 
B activation (13).
However, in contrast to its dominant-negative effect on
ASC-mediated NF-
 
 
 
B induction POP1 enhances ASC-
mediated caspase-1 activation, at least when overexpressed.
By binding the PYRIN domain of ASC, POP1 may induce
multimerization of ASC, leaving its CARD free for interac-
tion with pro–caspase-1. Multiple other examples of regula-
tory interactions among PYRIN domain–containing pro-
teins are likely to emerge as research in this field progresses.
These interactions certainly could involve PYRIN–PYRIN
interactions, but other domains associated with these pro-
teins could also mediate their interactions, especially NACHT
domains, which are known for their propensity to oligo-
merize. Interestingly, recent evidence suggests that NACHT
domains from different PAN family proteins can associate,
implying complex networks of protein heterooligomeriza-
tion mediated by NACHT–NACHT interactions (27). In-
terestingly, the human genome is predicted to encode pro-
teins that combine a NACHT and LRRs but lacking the
NH
 
2
 
-terminal effector domain region. Such proteins con-
ceivably could act as dominant-negative regulators of PANs,
relying on NACHT–NACHT interactions to thwart assem-
bly of functional signaling complexes.
 
A Role of PYRIN Proteins in Apoptosis?
 
Several PYRIN
proteins have been implicated in apoptosis, though the
mechanisms remain poorly defined. Overexpression of
ASC for example triggers apoptosis of some types of cells
(28), whereas antisense-mediated suppression of ASC ex-
pression reportedly reduces cell death in myeloid leukemia
cells (14). Coexpressing Pyrin with ASC can overcome its
proapoptotic action (29), suggesting that PYRIN–PYRIN
domain interactions are important determinants of whether
ASC modulates apoptosis. One likely mechanism for ASC-
induced apoptosis is caspase-1 activation, inasmuch as its
excessive activation can trigger activation of apoptotic cas-
pases, and caspase-1–dependent apoptosis was impaired in
macrophages from 
 
Asc
 
 
 
/
 
 
 
 mice (18). In this regard, both
the apical protease in the mitochondrial pathway, caspase-
9, and caspase-8, the pinnacle protease in the death recep-
tor pathway, have been implicated in ASC-induced apop-
tosis (28, 30). Also, macrophages from 
 
Pyrin
 
 
 
/
 
 
 
 mice
display impaired caspase-8 activity along with reduced sus-
ceptibility to apoptosis (20). Recently, ASC was suggested
to bind and activate the proapoptotic Bcl-2 family member
Bax, invoking a mitochondrial apoptosis pathway involving
cytochrome 
 
c
 
 release. This ASC/Bax mechanism for cell
death was implicated in a DNA damage response pathway,
where ASC expression is induced by activated p53 (31).
NALP1 involvement in the mitochondrial pathway for
apoptosis has also been reported (32). Similarly, TLRs, well
known for their role in innate immunity, are capable of
triggering caspase-dependent apoptosis in some contexts
(33). Further work is required to ascertain the circum-
stances where PYRIN domain–containing proteins partici-
pate in apoptosis regulation and the repertoire of apoptosis-
relevant proteins with which they interact. Like CARDs
and DDs, the PYRIN domains may operate at cross-roads
of inflammation and apoptosis.
 
PANs As Intracellular Pathogen-sensing Proteins.
 
Most
PAN family proteins, with the exception of PAN5 (Pynod),
contain LRRs similar to the extracellular LRR domains of
the TLRs (Fig. 1). The LRR domains of TLRs bind a vari-
ety of microbe-derived molecules and transduce signals into
cells via their intracellular Toll/IL-1 receptor (TIR) do-
mains (Fig. 1). Similarly, the genomes of plants, such as Ar-
abidopsis, contain as many as hundreds of resistance (R)
genes that encode host defense proteins combining patho-
gen-sensing LRRs with a NB-ARC domain, (a NACHT-
like fold) and various effector domains comprised of TIR-,
coiled-coil–, or leucine zipper–like domains (Fig. 1). One
of the downstream responses elicited via these R gene prod-
ucts is the hypersensitive response, where altruistic cell
death is induced to limit pathogen spread. R-gene products
are also implicated in regulation of a multiprotein complex
that may be likened to the IKK complex and the SCF ubiq-
uitin–ligase complex that targets I
 
 
 
B
 
 
 
 for destruction.
Their domain arrangement is reminiscent of PANs. Thus,
PAN family proteins represent excellent candidates for the
long-sought sensors of intracellular pathogens.
In plants, the LRRs have been shown to suppress activa-
tion of the R-gene protein, operating as autoinhibitory do-
mains with inhibition relieved upon binding pathogen- 
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derived molecules (34). Similarly deleting the LRRs from
mammalian PAN family proteins seems to boost their abil-
ity to activate caspase-1 or NF-
 
 
 
B. Thus, the LRRs may
act as a switch, converting PANs from inactive to active
conformations. Thus, one mechanism underlying periodic
fever syndromes might be uncontrolled formation of pro-
inflammatory signaling complexes, independently of sens-
ing pathogens. However, data complicating this simple in-
terpretation have come from the observation that Pynod
(PAN5/NALP10), which is the only PAN family member
lacking LRRs, blocks Cryopyrin and Ipaf (CLAN)–medi-
ated activation of caspase-1 and NF-
 
 
 
B (35).
Though no definitive evidence exists to date that the
LRRs of PANs bind microbial products, LRRs of the
closely related proteins, Nod1 and Nod2, have recently
been reported to bind bacterial muropeptides, leading to
NF-
 
 
 
B induction (36). Nod1, Nod2, and Ipaf are highly
similar to PANs, except that they contain CARDs instead
of PYRIN domains at their NH
 
2
 
 termini (Fig. 1). They are
also implicated in pro–caspase-1 and NF-
 
 
 
B activation,
undergoing oligomerization in response to invading gram-
negative bacteria (36). Consistent with this idea, macro-
phages from 
 
ipaf
 
 
 
/
 
 
 
 mice are defective in caspase-1 activa-
tion in response to intracellular pathogens but not TLR
agonists (18). NAIP and CIITA, which are structurally sim-
ilar to PAN proteins, containing NACHT and LRR do-
mains but lacking DDFs, are also implicated in host defense:
they have been shown to regulate host susceptibility to the
intracellular pathogen 
 
Listeria
 
 and class I histocompatibility
antigen expression, respectively (Fig. 1) (36).
Future research, therefore, should seek to define the ex-
ogenous or endogenous ligands for the LRRs of PAN fam-
ily proteins. Given that precedence exists for the LRRs of
TLRs binding nucleic acids (e.g., CpG DNA; poly I:C),
one topic worthy of exploration concerns the proinflam-
matory effects observed for some antisense oligonucleotides
and synthetic small interfering RNAs. Knowledge of the
sequence requirements for interactions of oligonucleotides
with LRRs of PANs might allow design of more side ef-
fect–free reagents. Interestingly, one of the PYRIN family
proteins, IFI16, has been implicated recently in DNA dam-
age and repair signaling (37), suggesting additional links be-
tween PYRIN domain–containing proteins and sensing of
altered nucleic acids.
 
Diverse Intracellular Locations of PYRIN Proteins.
 
The lo-
cation of a protein often says a lot about its function.
PYRIN proteins exhibit some interesting patterns of sub-
cellular location. Pyrin was originally predicted to function
as a RoRet family transcription factor. However, only one
alternative spliced isoform of Pyrin localizes to the nucleus,
whereas the full-length protein associates with tubulin and
actin, leading to speculation that Pyrin might regulate cyto-
skeletal organization in leukocytes (38). Interestingly, he-
reditary Pyrin mutants do not show altered cellular distri-
bution and still colocalize with ASC (39). In contrast,
Cryopyrin displays granular cytoplasmic localization (17).
Proteins of another branch of the PYRIN family, the
HIN200 proteins, such as human IFI16, AIM2, and MNDA
(Fig. 1), localize exclusively to the nucleus and associate
with various transcription factors via their HIN200 do-
mains, suggesting a role for some PYRIN proteins as mod-
ulators of gene expression (40). IFI16 was identified recently
as a BRCA1-associated protein enhancing p53-mediated
apoptosis in response to DNA damage (37). The PAN-
related protein, CIITA, also operates in the nucleus to con-
trol expression of MHC class I genes (41).
The adaptor protein ASC derives its name, “apoptotic-
associated speck-like protein containing a caspase recruit-
ment domain,” in part from its tendency to localize to
cytosolic specks when overexpressed or transcriptionally
induced (14). In gene transfection experiments, several
ASC-binding PYRIN proteins, including Pyrin, Cryopy-
rin, POP1, PAN6, PAN3, and zCaspy are recruited into
these specks via PYRIN–PYRIN interactions. Conceiv-
ably therefore, ASC and certain ASC-binding PYRIN pro-
teins, including Pyrin, might participate in cytosolic macro-
molecular complexes (signalosomes or inflammasomes) that
serve as scaffolds for achieving activation of caspases,
NF-
 
 
 
B–activating kinases, and perhaps other proteins in-
volved in host defense, inflammation, or apoptosis.
 
Regulation of PYRIN Family Gene Expression.
 
Although
expression of some PYRIN domain–containing proteins is
ubiquitous (PAN2, ASC), others are produced predomi-
nantly in cells directly involved in host defense, such as
macrophages, neutrophils, lymphocytes, and cells that play
pathogen barrier functions, such as intestinal epithelial cells
(Table I). The stimuli that modulate expression of PYRIN
proteins are only just beginning to be defined but include in-
flammatory cytokines and LPS. Expression of some PYRIN
domain–containing proteins is controlled by interferons, in-
cluding the HIN200 family members, Pyrin, and ASC. In-
flammatory mediators such as LPS and TNF
 
 
 
 up-regulate
expression of Cryopyrin, and its expression is also increased
at sites of inflammation (25). Likewise, Pyrin is induced as an
immediate-early gene by proinflammatory molecules (e.g.,
TNF
 
 
 
, LPS, and IFNs) but inducibility is inhibited by anti-
inflammatory cytokines (e.g., IL-4, IL-10, and TGF
 
 
 
) (42).
However, in mice the strongest expression of Pyrin appar-
ently occurs in response to IL-4 and IL-10 (20). Moreover,
evidence of diseases-associated alterations in PYRIN family
gene expression has begun to emerge. For example, 
 
ASC
 
gene silencing in association with DNA hypermethylation
has been observed in breast cancers, melanomas, and lung
cancers (43). 
 
ASC
 
 silencing might be advantageous for can-
cers due to its ability to: (a) induce apoptosis in the p53/Bax
pathway after DNA damage and (b) modulate activation of
NF-
 
 
 
B family transcription factors that control expression of
proteins involved in tumor recognition by cytolytic T cells
(44). Regardless of the explanation, studies of PYRIN pro-
tein expression in cancer are likely to provide new insights
into tumor biology, particularly given the close association
recognized between inflammation and malignancy.
 
Concluding Remarks.
 
Recent discovery of a large family
of genes encoding PYRIN domain proteins in mammalian 
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genomes opens a new window into innate immunity, in-
flammatory diseases, and host defense. At present, our un-
derstanding is relatively poor of the physiological roles,
molecular mechanisms, and modes of regulation of net-
works of PYRIN proteins. Only two PYRIN family
genes, 
 
Pyrin
 
 and 
 
Asc
 
, have been knocked out in mice thus
far (18, 20), and thus there is a need for more such experi-
ments aimed at uncovering the fundamental roles of these
genes in host defense and inflammation in vivo. However,
because of the divergent expansion and genetic drift of
these genes in mice relative to humans, mouse models of
relevance to human biology may be limited. Analysis of se-
rum and inflammatory cells derived from PFS patients sug-
gests that increased production of IL-1
 
 
 
 represents a com-
mon underlying mechanism (Fig. 2), the importance of
which is documented by the encouraging clinical responses
of MWS and PAPA patients to treatment with recombi-
nant IL-1 receptor antagonist (Anakinra) (3, 26). Thus, in-
appropriate production of IL-1 (also known as endogenous
pyrogen) appears to be tightly linked to PFS, playing a
causative role in the symptoms associated with these disor-
ders. The full nuances of the disturbances in regulatory net-
works of PYRIN–PYRIN and NACHT–NACHT inter-
actions caused by hereditary mutations in FPS proteins,
such as Cryopyrin, remain to be elucidated.
Although PYRIN proteins have been linked to certain
known mediators of immune regulation, namely caspase-1
and NF-
 
 
 
B, additional downstream efforts may await dis-
covery, particularly given the nuclear location of some
PYRIN proteins. Also, the adaptor proteins that link
PYRIN proteins to downstream effectors of host defense
certainly extend beyond ASC, given that only some of the
PYRIN proteins bind this bipartite adaptor. The prospect
that PANs with their LRRs might provide a mechanism
for sensing the presence of intracellular pathogens, thus
complementing the TLR system, is another exciting possi-
bility, but direct evidence is so far lacking that PAMPs bind
and activate these PANs. Thus, a high priority for future
research is elucidation of the identity of the ligands of LRRs
of PANs, including determination of whether endogenous
Figure 2. Potential molecular mechanisms
underlying PFSs. (A) PAN family proteins are
thought to sense pathogens via their LRR do-
mains, triggering NACHT domain–mediated
oligomerization, resulting in association with
the adaptor protein ASC and activation of
downstream effectors, including caspase-1 and
IKK complex by the induced proximity mecha-
nism. The ASC-associated Ser/Thr kinase
Cardiak might potentially provide the link to
IKK . Through PYRIN–PYRIN interactions,
family members such as POP1 may prevent
spontaneous activation of these downstream
effectors. (B) NALP1, which is a unique PAN
in that it contains COOH-terminal FIIND and
CARD domains, has been suggested to connect
via PYRIN–PYRIN interaction to ASC,
which then links to pro–caspase-1 by CARD–
CARD interaction. NALP1 further utilizes its
CARD to also recruit pro–caspase-5 into the
inflammasome (45), resulting in activation of
both caspases. (C) PANs, including Cryopyrin
and NALP2 were recently demonstrated to
form inflammasomes that also recruit ASC by
PYRIN–PYRIN interaction, which then links
to pro–caspase-1 by CARD–CARD association.
In addition, the CARD containing protein Cardi-
nal, which resembles the COOH-terminal
FIIND  and CARD domain structure of
NALP1, associates with these PANs via FIIND–
NACHT interaction and then recruits caspase-1
by CARD–CARD association, leading to acti-
vation of this caspase and secretion of bioactive
IL-1 . Consistent with an inhibitory role for
the LRR domain, this domain suppresses asso-
ciation of PANs and Cardinal, suggesting that
LRR ligands might be required to induce this
interaction. (D) Theoretically, PANs might also
link via Cardinal to the IKK complex. 
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ligands may exist for these proteins, analogous to some of
the TLRs that can be stimulated by heat shock proteins re-
leased from dying cells at times of cellular stress and tissue
injury. Finally, the identification of genes encoding
PYRIN domain proteins offers new avenues of exploration
for attempts to understand the origins of other inflamma-
tory and autoimmune diseases.
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